- Home
- AZI vs CTXR Comparison
AZI vs CTXR Comparison
Compare AZI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- CTXR
- Stock Information
- Founded
- AZI 2010
- CTXR 2007
- Country
- AZI China
- CTXR United States
- Employees
- AZI N/A
- CTXR N/A
- Industry
- AZI
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- CTXR Health Care
- Exchange
- AZI Nasdaq
- CTXR Nasdaq
- Market Cap
- AZI 25.2M
- CTXR 20.8M
- IPO Year
- AZI 2024
- CTXR N/A
- Fundamental
- Price
- AZI $0.21
- CTXR $1.16
- Analyst Decision
- AZI
- CTXR Strong Buy
- Analyst Count
- AZI 0
- CTXR 3
- Target Price
- AZI N/A
- CTXR $53.00
- AVG Volume (30 Days)
- AZI 3.5M
- CTXR 371.1K
- Earning Date
- AZI 01-01-0001
- CTXR 08-12-2025
- Dividend Yield
- AZI N/A
- CTXR N/A
- EPS Growth
- AZI N/A
- CTXR N/A
- EPS
- AZI N/A
- CTXR N/A
- Revenue
- AZI $156,466,000.00
- CTXR N/A
- Revenue This Year
- AZI N/A
- CTXR N/A
- Revenue Next Year
- AZI N/A
- CTXR $851.67
- P/E Ratio
- AZI N/A
- CTXR N/A
- Revenue Growth
- AZI 32.90
- CTXR N/A
- 52 Week Low
- AZI $0.18
- CTXR $0.65
- 52 Week High
- AZI $3.20
- CTXR $13.52
- Technical
- Relative Strength Index (RSI)
- AZI 45.82
- CTXR 42.87
- Support Level
- AZI $0.20
- CTXR $1.13
- Resistance Level
- AZI $0.21
- CTXR $1.20
- Average True Range (ATR)
- AZI 0.02
- CTXR 0.05
- MACD
- AZI 0.00
- CTXR 0.00
- Stochastic Oscillator
- AZI 38.40
- CTXR 32.14
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.